Abstract

Abstract Autoimmune cholangitis arises from abnormal innate and adaptive immune responses in liver and T cells are critical drivers in this process, but little is known about the regulation of their functional behavior during disease development. We previously reported that mice with a T cell-restricted expression of a dominant negative form of transforming growth factor beta receptor type II (dnTGFbRII) spontaneously develop autoimmune cholangitis that resembles human primary biliary cholangitis (PBC). Adoptive transfer of CD8+ but not CD4+ T cells into Rag1−/− mice reproduced the disease, demonstrating a critical role for CD8 T cells in pathogenesis. Herein, we took advantage of SOMA scan technology to perform proteomic analysis of serum samples from dnTGFbRII and B6 control mice at different ages. In addition, we analyzed CD8 protein profiles after adoptive transfer of splenic CD8+ cells into Rag1−/− recipients. The use of the unique aptamer technology of SOMA scans reveals critical distinct profiles of CD8 cells, which are key to biliary mediation. 254 proteins were significantly increased, while 216 proteins significantly decreased in recipient hepatic CD8+ cells compared to donor splenic CD8+ cells. In contrast to donor splenic CD8+ cells, recipient hepatic CD8+ cells express distinct protein profiles involved in chemokine signaling, focal adhesion, T cell receptor and natural killer cell mediated cytotoxicity pathways.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.